-
Featured
Reduced dosing: a possible crisis response to ART stockouts and closed clinics
5 May 2025. Related: Special reports, Antiretrovirals, Treatment strategies, Treatment access.
-
IAS-USA update in drug resistance mutations (2025)
29 May 2025. Related: Early access, Drug resistance.
-
Vaccination is effective in limiting mpox progression – but lower efficacy in people living with HIV
27 May 2025. Related: Journal scan, Early access, mpox.
-
US update guidelines for statin use in people living with HIV
26 May 2025. Related: Early access, Guidelines, Weight, diabetes, metabolic complications.
-
HIV activists in the US call for action in JID and Zachie Achmat brings South African perspective in the Lancet
26 May 2025. Related: Journal scan, Early access, Treatment advocacy.
-
Combining injectable lenacapavir and cabotegravir-LA
23 May 2025. Related: Journal scan, Antiretrovirals, Treatment strategies, Treatment access.
-
Scientific, legal and ethical crisis from halting ongoing NIH studies: TAG statement
22 May 2025. Related: Early access, Special reports, Treatment access, Women's health, Paediatric care, Cure-related research, Research studies.
-
Impact of US funding cuts in Malawi and South Africa: ITPC community report
20 May 2025. Related: Journal scan, Treatment access.
-
The Denver Principles – riso print by Jane Shepherd to support i-Base
17 May 2025. Related: Special reports.
-
US CDC updated guidelines on PEP (May 2025)
10 May 2025. Related: Early access, Guidelines, HIV prevention and transmission.
-
Closed clinics and limited ART in Zimbabwe, PEPFAR and UNAIDS news
4 May 2025. Related: Early access, Treatment access.
-
Future meetings and webinars 2025
1 May 2025. Related: Future meetings.
-
Yellow card reporting scheme for doctors and patients in the UK
1 May 2025. Related: Side effects.
-
The RIO study: Q&A about controlling HIV with bNAbs
21 April 2025. Related: Early access, Conference reports, Cure-related research, CROI 32 San Francisco 2025.
-
Lenacapavir EAP in the UK closed to new referrals: NHS England and Gilead fail to agree a price after more than two years
20 April 2025. Related: Early access, Antiretrovirals, Treatment access, Drug resistance, BHIVA news.
-
CROI 2025: Webcasts and other resources now open access
16 April 2025. Related: Conference reports, CROI 32 San Francisco 2025.
-
Continued reports from CROI 2025
13 April 2025. Related: Conference reports, Conference index, CROI 32 San Francisco 2025.
-
Viral failure on CAB/RPV-LA: overcoming drug resistance with second-generation INSTIs
13 April 2025. Related: Journal scan, Early access, Treatment strategies, Drug resistance.
-
CROI 2025: LAPTOP, EC rebounds after 32 years, two more HSCT cures
12 April 2025. Related: Conference reports, Antiretrovirals, Treatment strategies, CROI 32 San Francisco 2025.
-
Lancet Commission on gender justice and equality
9 April 2025. Related: Journal scan.
-
Changes to US policy jeopardises the lives of 500,000 children living with HIV by 2030
8 April 2025. Related: Treatment access.
-
CROI 2025: Rebecca Denison gives opening community talk on 40 years of HIV
7 April 2025. Related: Conference reports, Treatment advocacy, CROI 32 San Francisco 2025.
-
Lancet HIV recognises Transgender Day of Visibility and the importance of gender-affirming hormones in HIV care
3 April 2025. Related: Journal scan, Early access, Special reports, Treatment access.
-
CROI 2025: BHIVA best of CROI feedback now online
1 April 2025. Related: Conference reports, On the web, CROI 32 San Francisco 2025.
-
People living with HIV need two shots of the mpox vaccine and likely a booster after two years
1 April 2025. Related: Journal scan, mpox.
-
CROI 2025: Two bNAbs enable viral suppression off-ART in African women in the FRESH cohort
1 April 2025. Related: Conference reports, Cure-related research, CROI 32 San Francisco 2025.
-
Cuts in aid: up to 10 million new HIV infections and almost 3 million related deaths by 2030
28 March 2025. Related: Journal scan, Treatment access.
-
Stopping ART safely if your clinic is closed or runs out of meds: a practical guide
25 March 2025. Related: Special reports, Treatment strategies.
-
Webinar on stopping ART if your clinic is closed: practical facts on safety and risk
24 March 2025. Related: Special reports, Treatment strategies, Treatment access, On the web.
-
CROI 2025: Introduction to this year’s conference
22 March 2025. Related: Conference reports, Conference index, CROI 32 San Francisco 2025.
-
CROI 2025: RIO study: Dual-bNABs keep viral load undetectable off-ART – plus a potential first case of vaccine-like HIV remission
21 March 2025. Related: Conference reports, Cure-related research, CROI 32 San Francisco 2025.
-
CROI 2025: Switching to daily fixed-dose doravirine/islatravir: two randomised phase 3 studies
20 March 2025. Related: Conference reports, Antiretrovirals, CROI 32 San Francisco 2025.
-
CROI 2025: Tecovirimat has no benefit against mpox in STOMP study
18 March 2025. Related: Conference reports, mpox, CROI 32 San Francisco 2025.
-
CROI 2025: Ensitrelvir significantly reduces risk of developing COVID-19 after household exposure
18 March 2025. Related: Conference reports, COVID-19, CROI 32 San Francisco 2025.
-
CROI 2025: N6LS: 4-monthly injectable bNAb with monthly injectable cabotegravir
18 March 2025. Related: Conference reports, Antiretrovirals, CROI 32 San Francisco 2025.
-
Summary of Australian guidelines for anal cancer screening in people living with HIV
18 March 2025. Related: Guidelines.
-
CROI 2025: Reducing Biktarvy from daily to only once, twice or three times a week
17 March 2025. Related: Conference reports, Antiretrovirals, Treatment strategies, CROI 32 San Francisco 2025.
-
CROI 2025: Potential for once-yearly lenacapavir injections
16 March 2025. Related: Conference reports, Antiretrovirals, PK and drug interactions, HIV prevention and transmission, CROI 32 San Francisco 2025.
-
CROI 2025: Delegates send open letter to protest US cuts
12 March 2025. Related: Conference reports, Treatment advocacy, CROI 32 San Francisco 2025.
-
CROI 2025: Stand Up For Science rally against Trump funding freeze
9 March 2025. Related: Conference reports, Treatment advocacy, CROI 32 San Francisco 2025.
-
HIV and vaccine denialist is proposed to head the US NIH: further alarm for global science
7 March 2025. Related: Treatment advocacy.
-
Global update: 90-day review ended early and cancelled 10,000 grants, millions of people will suffer
1 March 2025. Related: Special reports, Treatment access.
-
Responses to the UK government slashing international aid by 40%
26 February 2025. Related: Treatment access, Treatment advocacy.
-
Deleted words from official documents: LGBTQ, diversity, inclusion, transgender
26 February 2025. Related: Treatment access, Treatment advocacy.
-
Country update from Nigeria: current impact on HIV services
22 February 2025. Related: Special reports, Treatment access.
-
Semaglutide reduces alcohol and cigarette use in a randomised phase 2 study
12 February 2025. Related: Weight, diabetes, metabolic complications, Coinfections and complications.
-
News and resources linked to changes in US policy on international aid
7 February 2025. Related: Special reports.
-
Impact of US elections and executive orders on global health: waiver covers PEPFAR with restrictions
7 February 2025. Related: Special reports, Treatment access, Treatment advocacy.
-
IAS public letter: Why HIV could be poised for a monumental comeback
6 February 2025. Related: Treatment access, On the web.
-
Lenacapavir for PrEP submitted to EMA for EU and global use
4 February 2025. Related: Antiretrovirals, HIV prevention and transmission.